Detalhe da pesquisa
1.
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors.
bioRxiv
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585724
2.
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors.
bioRxiv
; 2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778419
3.
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.
Sci Adv
; 9(47): eadg8876, 2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000020
4.
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.
Neuro Oncol
; 25(11): 2044-2057, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246765
5.
Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic Osteosarcoma.
Mol Cancer Ther
; 19(12): 2528-2541, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32999043
6.
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma.
Bone
; 136: 115353, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251854
7.
Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.
Cancer Res
; 79(5): 905-917, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674530